Page last updated: 2024-12-07

hypobromous acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID83547
CHEBI ID29249
MeSH IDM0089736

Synonyms (22)

Synonym
13517-11-8
CHEBI:29249
bromanol
hbro
hypobromige saeure
hydroxidobromine
[broh]
hypobromous acid
hobr
unii-ght9bv419j
ght9bv419j ,
hydroxyl-bromine
oxayl bromide
hydroxy-bromine
bromo-alcohol
hydroxybromide
CUILPNURFADTPE-UHFFFAOYSA-N
hydrogen oxybromide (hobr)
hypobromous acid (hobr)
Q414695
Q27104091
DTXSID701024864

Research Excerpts

Overview

Hypobromous acid (HOBr) is a powerful oxidant produced by stimulated neutrophils and eosinophils. It has been recently found to be associated with a variety of diseases.

ExcerptReferenceRelevance
"Hypobromous acid (HOBr) is an important reactive oxygen species and has been recently found to be associated with a variety of diseases. "( A novel near-infrared fluorescent probe for detection of hypobromous acid and its bioimaging applications.
Liu, H; Ma, Y; Qu, W; Yu, F; Zhang, X, 2019
)
2.2
"Hypobromous acid (HOBr) is a powerful oxidant produced by stimulated neutrophils and eosinophils. "( Inhibition of lysozyme by taurine dibromamine.
PetrĂ´nio, MS; Ximenes, VF, 2013
)
1.83
"Hypobromous acid (HOBr) is an inorganic acid produced by the oxidation of the bromide anion (Br(-)). "( Hypobromous acid, a powerful endogenous electrophile: Experimental and theoretical studies.
de Souza, AR; Morgon, NH; Ximenes, VF, 2015
)
3.3

Effects

ExcerptReferenceRelevance
"Hypobromous acid (HOBr) has been approved for various applications in meat processing, but the efficacy of HOBr as a hide antimicrobial has not been determined."( Efficacy of hypobromous acid as a hide-on carcass antimicrobial intervention.
Kalchayanand, N; Koohmaraie, M; Schmidt, JW; Wang, R; Wheeler, TL, 2012
)
1.48

Dosage Studied

ExcerptRelevanceReference
" These values are lower than the maximal therapeutic plasma concentrations of acetaminophen (< or =150microM) resulting from typical dosing regimes."( Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations.
Davies, MJ; Fu, S; Graham, GG; Hawkins, CL; Kajer, T; Keh, JS; Kettle, AJ; Koelsch, M; Mallak, R; Milligan, MK; Newsham, DW; Nguyen, LQ; Pattison, DI; Rees, MD; Scott, KF; Ziegler, JB, 2010
)
0.36
" Under the condition of the same ozone dosage and reaction time, adding of Cl- and SO(4)2- will inhibit the formation of bromate during ozonation, while adding of HCOC3- significantly will increase the production of bromate."( [Effects of Anions on Bromate Formation During Ozonation of Bromide-Containing Water].
Liu, LG; Wu, CD; Wu, Y; Yuan, BJ, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
bromine oxoacid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (131)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.05)18.7374
1990's6 (4.58)18.2507
2000's43 (32.82)29.6817
2010's60 (45.80)24.3611
2020's18 (13.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.06 (24.57)
Research Supply Index4.92 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (4.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other130 (95.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]